Prediction of mutations engineered by randomness in H5N1 hemagglutinins of influenza a virus

Amino Acids

Volumn 35, Issue 2, 2008, Pages 365-373

  Wu, G ^a   Yan, S ^a  

^a DreamSciTech Consulting   (China)

Author keywords

Amino acid; Hemagglutinin; Influenza; Mutation; Neural network

Indexed keywords

AMINO ACID; MUTANT PROTEIN; VIRUS HEMAGGLUTININ;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; ARTIFICIAL NEURAL NETWORK; COMPUTER PREDICTION; CONTROLLED STUDY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; KINETICS; LOGISTIC REGRESSION ANALYSIS; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROBABILITY SAMPLE; PROTEIN ENGINEERING; PROTEIN LOCALIZATION; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; VIRUS MUTATION;

AMINO ACID SEQUENCE; AMINO ACIDS; COMPUTER SIMULATION; HEMAGGLUTININS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MUTAGENESIS; MUTATION; NEURAL NETWORKS (COMPUTER); PREDICTIVE VALUE OF TESTS; PROTEIN ENGINEERING;

INFLUENZA A VIRUS;

EID: 49749107879     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-007-0602-4     Document Type: Article

References (107)

1. IW Althaus JJ Chou AJ Gonzales MR Diebel KC Chou FJ Kezdy DL Romero PA Aristoff WG Tarpley F Reusser 1993a Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E J Biol Chem 268 6119 6124
2. IW Althaus JJ Chou AJ Gonzales MR Diebel KC Chou FJ Kezdy DL Romero PA Aristoff WG Tarpley F Reusser 1993b Kinetic studies with the nonnucleoside HIV-1 reverse transcriptase inhibitor U-88204E Biochemistry 32 6548 6554
3. IW Althaus AJ Gonzales JJ Chou MR Diebel KC Chou FJ Kezdy DL Romero PA Aristoff WG Tarpley F Reusser 1993c The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase J Biol Chem 268 14875 14880
4. JJ Chou 1993a A formulation for correlating properties of peptides and its application to predicting human immunodeficiency virus protease-cleavable sites in proteins Biopolymers 33 1405 1414
5. JJ Chou 1993b Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach J Protein Chem 12 291 302
6. KC Chou 1993c A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins J Biol Chem 268 16938 16948
7. KC Chou 1996 Prediction of HIV protease cleavage sites in proteins Anal Biochem 233 1 14
8. KC Chou 2004a Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor Biochem Biophys Res Commun 319 433 438
9. KC Chou 2004b Insights from modelling the tertiary structure of BACE2 J Proteome Res 3 1069 1072
10. KC Chou 2004c Molecular therapeutic target for type-2 diabetes J Proteome Res 3 1284 1288
11. KC Chou 2004d Structural bioinformatics and its impact to biomedical science Curr Med Chem 11 2105 2134
12. KC Chou 2004e Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5 Biochem Biophys Res Commun 316 636 642
13. KC Chou 2005a Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein J Proteome Res 4 1681 1686
14. KC Chou 2005b Modeling the tertiary structure of human cathepsin-E Biochem Biophys Res Commun 331 56 60
15. KC Chou D Jones RL Heinrikson 1997 Prediction of the tertiary structure and substrate binding site of caspase-8 FEBS Lett 419 49 54
16. KC Chou FJ Kezdy F Reusser 1994 Steady-state inhibition kinetics of processive nucleic acid polymerases and nucleases Anal Biochem 221 217 230
17. KC Chou AG Tomasselli RL Heinrikson 2000 Prediction of the tertiary structure of a caspase-9/inhibitor complex FEBS Lett 470 249 256
18. KC Chou KD Watenpaugh RL Heinrikson 1999 A model of the complex between cyclin-dependent kinase 5(Cdk5) and the activation domain of neuronal Cdk5 activator Biochem Biophys Res Commun 259 420 428
19. KC Chou DQ Wei QS Du S Sirois WZ Zhong 2006 Progress in computational approach to drug development against SARS Curr Med Chem 13 3263 3270
20. KC Chou DQ Wei WZ Zhong 2003 Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS Biochem Biophys Res Comm 308 148 151 Erratum: ibid, 2003, 310, 675
21. Demuth H, Beale M (2001) Neural Network Toolbox for Use with MatLab. Version 4
22. NR Draper H Smith 1981 Applied regression analysis 2 Wiley New York
23. QS Du S Wang DQ Wei S Sirois KC Chou 2005a Molecular modelling and chemical modification for finding peptide inhibitor against SARS CoV Mpro Anal Biochem 337 262 270
24. QS Du SQ Wang ZQ Jiang WN Gao YD Li DQ Wei KC Chou 2005b Application of bioinformatics in search for cleavable peptides of SARS-CoV Mpro and chemical modification of octapeptides Med Chem 1 209 213
25. QS Du H Sun KC Chou 2007a Inhibitor design for SARS coronavirus main protease based on "distorted key theory" Med Chem 3 1 6
26. Du QS, Wang SQ, Chou KC (2007b) Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Comm; doi: 10.1016/j.bbrc.2007. 08.025
27. AP Elhammer RA Poorman E Brown LL Maggiora JG Hoogerheide FJ Kezdy 1993 The specificity of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase as inferred from a database of in vivo substrates and from the in vitro glycosylation of proteins and peptides J Biol Chem 268 10029 10038
28. BS Everitt 1999 Chance rules: an informal guide to probability, risk, and statistics Springer New York
29. W Feller 1968 An introduction to probability theory and its applications 3 I Wiley New York 34 40
30. WM Fitch RM Bush CA Bender NJ Cox 1997 Long term trends in the evolution of H(3) HA1 human influenza type A Proc Natl Acad Sci USA 94 7712 7718
31. YR Gan H Huang YD Huang CM Rao Y Zhao JS Liu L Wu DQ Wei 2006 Synthesis and activity assess of an octapeptide inhibitor designed for SARS coronavirus main proteinase Peptides 27 622 625
32. N Gao S Yan G Wu 2006 Pattern of positions sensitive to mutations in human haemoglobin α-chain Protein Pept Lett 13 101 107
33. WN Gao DQ Wei Y Li H Gao WR Xu AX Li KC Chou 2007 Agaritine and its derivatives are potential inhibitors against HIV proteases Med Chem 3 221 226
34. MJR Healy 1979 Outliers in clinical chemistry quality-control schemes Clin Chem 25 675 677
35. DW Hosmer Jr S Lemeshow 2000 Applied logistic regression 2 Wiley New York
36. Influenza virus resources (2006) http://www.ncbi.nlm.nih.gov/genomes/FLU/ Database/multiple.cgi
37. L Li DQ Wei JF Wang KC Chou 2007 Computational studies of the binding mechanism of calmodulin with chrysin Biochem Biophys Res Comm 358 1102 1107
38. MathWorks Inc (2001) MatLab - the language of technical computing. version 6.1.0.450, release 12.1
39. RA Poorman AG Tomasselli RL Heinrikson FJ Kezdy 1991 A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base J Biol Chem 266 14554 14561
40. Prosite (2002) A dictionary of protein sites and patterns user manual. http://www.expasy.ch/prosite/
41. S Sirois DQ Wei QS Du KC Chou 2004 Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points J Chem Inf Comput Sci 44 1111 1122
42. Systat Software Inc (2004) Systat for windows, version 11.00.01
43. TB Thompson KC Chou C Zheng 1995 Neural network prediction of the HIV-1 protease cleavage sites J Theor Biol 177 369 379
44. JF Wang DQ Wei L Li SY Zheng YX Li KC Chou 2007a 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design Biochem Biophys Res Commun 355 513 519 Corrigendum: ibid, 2007, 357, 330
45. JF Wang DQ Wei Y Lin YH Wang HL Du KC Chou 2007c Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP Biochem Biophys Res Comm 359 323 329
46. SQ Wang QS Du KC Chou 2007b Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases Biochem Biophys Res Comm 354 634 640
47. DQ Wei S Sirois QS Du HR Arias KC Chou 2005 Theoretical studies of Alzheimer's disease drug candidate [(2,4-dimethoxy) benzylidene]-anabaseine dihydrochloride (GTS-21) and its derivatives Biochem Biophys Res Commun 338 1059 1064
48. DQ Wei QS Du H Sun KC Chou 2006a Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands Biochem Biophys Res Commun 344 1048 1055
49. DQ Wei R Zhang QS Du WN Gao Y Li H Gao SQ Wang X Zhang AX Li S Sirois KC Chou 2006b Anti-SARS drug screening by molecular docking Amino Acids 31 73 80
50. H Wei R Zhang C Wang H Zheng KC Chou DQ Wei 2007 Molecular insights of SAH enzyme catalysis and their implication for inhibitor design J Theor Biol 244 692 702
51. DC Wiley JJ Skehel 1987 The structure and function of the hemagglutinin membrane glycoprotein of influenza virus Annu Rev Biochem 56 365 394
52. 2 affinity Comp Haematol Int 9 148 151
53. G Wu 2000a Frequency and Markov chain analysis of amino acid sequence of human glutathione reductase Biochem Biophys Res Commun 268 823 826
54. G Wu 2000b Frequency and Markov chain analysis of amino acid sequence of human tumor necrosis factor Cancer Lett 153 145 150
55. G Wu 2000c Frequency and Markov chain analysis of amino acid sequences of mouse p53 Hum Exp Toxicol 19 535 539
56. G Wu 2000d Frequency and Markov chain analysis of the amino acid sequence of human alcohol dehydrogenase α-chain Alcohol Alcohol 35 302 306
57. G Wu 2000e Frequency and Markov chain analysis of the amino acid sequence of sheep p53 protein J Biochem Mol Biol Biophys 4 179 185
58. G Wu 2000f The first, second and third order Markov chain analysis on amino acids sequence of human tyrosine aminotransferase and its variant causing tyrosinemia type II Pediatr Relat Top 39 37 47
59. G Wu 2000g The first, second, third and fourth order Markov chain analysis on amino acids sequence of human dopamine β-hydroxylase Mol Psychiatry 5 448 451
60. G Wu S Yan 2000a Frequency and Markov chain analysis of amino acids sequence of human platelet-activating factor acetylhydrolase α-subunit and its variant causing the lissencephaly syndrome Pediatr Relat Top 39 513 526
61. G Wu S Yan 2000b Prediction of two- and three-amino acid sequence of human acute myeloid leukemia 1 protein from its amino acid composition Comp Haematol Int 10 85 89
62. G Wu S Yan 2000c Prediction of two- and three-amino acid sequences of Citrobacter Freundii β-lactamase from its amino acid composition J Mol Microbiol Biotechnol 2 277 281
63. G Wu S Yan 2000d Prediction of distributions of amino acids and amino acid pairs in human haemoglobin α-chain and its seven variants causing α-thalassemia from their occurrences according to the random mechanism Comp Haematol Int 10 80 84
64. G Wu S Yan 2001a Frequency and Markov chain analysis of amino acid sequences of human connective tissue growth factor J Mol Model 5 120 124
65. G Wu S Yan 2001b Prediction of presence and absence of two- and three-amino acid sequence of human monoamine oxidase B from its amino acid composition according to the random mechanism Biomol Eng 18 23 27
66. G Wu S Yan 2001c Prediction of presence and absence of two- and three-amino acid sequence of human tyrosinase from their amino acid composition and related changes in human tyrosinase variant causing oculocutaneous albinism Pediatr Relat Top 40 153 166
67. G Wu S Yan 2001d Analysis of distributions of amino acids, amino acid pairs and triplets in human insulin precursor and four variants from their occurrences according to the random mechanism J Biochem Mol Biol Biophys 5 293 300
68. G Wu S Yan 2001e Analysis of distributions of amino acids and amino acid pairs in human tumor necrosis factor precursor and its eight variants according to random mechanism J Mol Model 7 318 323
69. G Wu S Yan 2002a Determination of amino acid pairs sensitive to variants in human low-density lipoprotein receptor precursor by means of a random approach J Biochem Mol Biol Biophys 6 401 406
70. G Wu S Yan 2002b Estimation of amino acid pairs sensitive to variants in human phenylalanine hydroxylase protein by means of a random approach Peptides 23 2085 2090
71. G Wu S Yan 2002c Random analysis of presence and absence of two- and three-amino acid sequences and distributions of amino acids, two- and three-amino acid sequences in bovine p53 protein Mol Biol Today 3 31 37
72. G Wu S Yan 2002d Analysis of distributions of amino acids in the primary structure of apoptosis regulator Bcl-2 family according to the random mechanism J Biochem Mol Biol Biophys 6 407 414
73. G Wu S Yan 2002e Analysis of distributions of amino acids in the primary structure of tumor suppressor p53 family according to the random mechanism J Mol Model 8 191 198
74. G Wu S Yan 2002f Randomness in the primary structure of protein: methods and implications Mol Biol Today 3 55 69
75. G Wu S Yan 2003a Analysis of amino acid pairs sensitive to variants in human collagen α5(IV) chain precursor by means of a random approach Peptides 24 347 352
76. G Wu S Yan 2003b Determination of amino acid pairs in human haemoglobulin α-chain sensitive to variants by means of a random approach Comp Clin Pathol 12 21 25
77. G Wu S Yan 2003c Determination of amino acid pairs in human p53 protein sensitive to mutations/variants by means of a random approach J Mol Model 9 337 341
78. G Wu S Yan 2003d Determination of amino acid pairs in Von Hippel-Lindau disease tumour suppressor (G7 protein) sensitive to variants by means of a random approach J Appl Res 3 512 520
79. G Wu S Yan 2003e Determination of amino acid pairs sensitive to variants in human β-glucocerebrosidase by means of a random approach Protein Eng 16 195 199
80. G Wu S Yan 2003f Determination of amino acid pairs sensitive to variants in human Bruton's tyrosine kinase by means of a random approach Mol Simul 29 249 254
81. G Wu S Yan 2003g Determination of amino acid pairs sensitive to variants in human coagulation factor IX precursor by means of a random approach J Biomed Sci 10 451 454
82. G Wu S Yan 2003h Prediction of amino acid pairs sensitive to mutations in the spike protein from SARS related coronavirus Peptides 24 1837 1845
83. G Wu S Yan 2004a Amino acid pairs sensitive to variants in human collagen α1(I) chain precursor EXCLI J 3 10 19
84. G Wu S Yan 2004b Susceptible amino acid pairs in variants of human collagen α1(III) chain precursor EXCLI J 3 20 28
85. G Wu S Yan 2004c Determination of amino acid pairs sensitive to variants in human copper-transporting ATPase 2 Biochem Biophys Res Commun 319 27 31
86. G Wu S Yan 2004d Fate of 130 hemagglutinins from different influenza A viruses Biochem Biophys Res Commun 317 917 924
87. G Wu S Yan 2004e Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus Peptides 25 901 908
88. G Wu S Yan 2004f Determination of sensitive positions to mutations in human p53 protein Biochem Biophys Res Commun 321 313 319
89. G Wu S Yan 2005a Amino acid pairs susceptible to variants in human protein C precursor Protein Pept Lett 10 491 494
90. G Wu S Yan 2005b Mutation features of 215 polymerase proteins from different influenza A viruses Med Sci Monit 11 BR367 BR372
91. G Wu S Yan 2005c Reasoning of spike glycoproteins being more vulnerable to mutations among 158 coronavirus proteins from different species J Mol Model 11 8 16
92. G Wu S Yan 2005d Searching of main cause leading to severe influenza A virus mutations and consequently to influenza pandemics/epidemics Am J Infect Dis 1 116 123
93. G Wu S Yan 2005e Prediction of mutation trend in hemagglutinins and neuraminidases from influenza A viruses by means of cross-impact analysis Biochem Biophys Res Commun 326 475 482
94. G Wu S Yan 2005f Timing of mutation in hemagglutinins from influenza A virus by means of unpredictable portion of amino acid pair and fast Fourier transform Biochem Biophys Res Commun 333 70 78
95. G Wu S Yan 2005g Determination of mutation trend in proteins by means of translation probability between RNA codes and mutated amino acids Biochem Biophys Res Commun 337 692 700
96. G Wu S Yan 2006a Determination of mutation trend in hemagglutinins by means of translation probability between RNA codons and mutated amino acids Protein Pept Lett 13 601 609
97. G Wu S Yan 2006b Fate of influenza A virus proteins Protein Pept Lett 13 377 384
98. G Wu S Yan 2006c Timing of mutation in hemagglutinins from influenza A virus by means of amino acid distribution rank and fast Fourier transform Protein Pept Lett 13 143 148
99. G Wu S Yan 2006d Mutation trend of hemagglutinin of influenza A virus: a review from computational mutation viewpoint Acta Pharmacol Sin 27 513 526
100. G Wu S Yan 2006e Prediction of possible mutations in H5N1 hemagglutinins of influenza A virus by means of logistic regression Comp Clin Pathol 15 255 261
101. G Wu S Yan 2006f Prediction of mutations in H5N1 hemagglutinins from influenza A virus Protein Pept Lett 13 971 976
102. G Wu S Yan 2007a Improvement of model for prediction of hemagglutinin mutations in H5N1 influenza viruses with distinguishing of arginine, leucine and serine Protein Pept Lett 14 191 196
103. G Wu S Yan 2007b Improvement of prediction of mutation positions in H5N1 hemagglutinins of influenza A virus using neural network with distinguishing of arginine, leucine and serine Protein Pept Lett 14 465 470
104. Wu G, Yan S (2007c) Prediction of mutations initiated by internal power in H3N2 hemagglutinins of influenza A virus from North America. Int J Pept Res Ther, http://dx.doi.org/10.1007/s10989-007-9104-1
105. Wu G, Yan S (2007d) Prediction of mutations engineered by randomness in H5N1 neuraminidases from influenza A virus. Amino Acids, http://dx.doi.org/10. 1007/s00726-007-0579-z
106. G Wu S Yan 2007e Translation probability between RNA codons and translated amino acids, and its applications to protein mutations MH Ostrovskiy Leading-edge Messenger RNA Research Communications Nova Science Publishers New York 47 65 Chapter 3
107. R Zhang DQ Wei QS Du KC Chou 2006 Molecular modeling studies of peptide drug candidates against SARS Med Chem 2 309 314